help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 19, 2003
Molecular Endocrinology, doi:10.1210/me.2003-0001
Molecular Endocrinology Vol. 0, No. 2003 200300011-
doi:10.1210/me.2003-0001
Copyright © 2003 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
17/9/1704    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holt, J. A.
Right arrow Articles by Billin, A. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holt, J. A.
Right arrow Articles by Billin, A. N.

Submitted on January 2, 2003
Accepted on June 11, 2003

Helix 1/helix 8 Interactions Influence the Activity of Nuclear Receptor Ligand Binding Domains

Jason A. Holt1, Thomas G. Consler1, Shawn P. Williams1, Andrea H. Ayscue1, Lisa M. Leesnitzer1, G. Bruce Wisely1, and Andrew N. Billin1*

1 Nuclear Receptor Discovery Research, GlaxoSmithKline Research and Development, Research Triangle Park, North Carolina 27709-3398

* To whom correspondence should be addressed. E-mail: andrew.n.billin{at}gsk.com.

The ligand binding domain (LBD) of apo-nuclear receptors (NRs) in solution is thought to be a very dynamic structure with many possible conformations. Upon ligand binding, the structure is stabilized to a more rigid conformation. The Dynamic Stabilization assay is a LBD re-assembly assay that takes advantage of the high specificity of the intramolecular interactions that comprise the ligand bound LBD. Here, we demonstrate Dynamic Stabilization for the NRs PPAR{gamma} and NGFIB{beta}, and identify residues important for stabilization of the intramolecular interactions induced by PPAR{gamma} ligands. Site directed mutatgenesis studies identified residues in helix 1 and helix 8 required for LBD re-assembly. Further, disrupting the helix 1/helix 8 interaction in the context of the holo-LBD alters the response of the receptor in a compound specific manner, suggesting that residues far from the ligand binding pocket can influence the stability of the ligand bound receptor. Thus, these results support and extend models of the apo-LBD of PPAR{gamma} as a dynamic structure.

NURSA Molecule Pages Link:

Nuclear Receptors:   PPARγ  |  NGFIB
Ligands:   GW 1929  |  Rosiglitazone



This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
P. Carlsson, K. F. Koehler, and L. Nilsson
Glucocorticoid Receptor Point Mutation V571M Facilitates Coactivator and Ligand Binding by Structural Rearrangement and Stabilization
Mol. Endocrinol., August 1, 2005; 19(8): 1960 - 1977.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society